Cargando…
Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model
VAPB is a ubiquitously expressed, ER-resident adaptor protein involved in interorganellar lipid exchange, membrane contact site formation, and membrane trafficking. Its mutant form, P56S-VAPB, which has been linked to a dominantly inherited form of Amyotrophic Lateral Sclerosis (ALS8), generates int...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237408/ https://www.ncbi.nlm.nih.gov/pubmed/25409455 http://dx.doi.org/10.1371/journal.pone.0113416 |
_version_ | 1782345341703553024 |
---|---|
author | Genevini, Paola Papiani, Giulia Ruggiano, Annamaria Cantoni, Lavinia Navone, Francesca Borgese, Nica |
author_facet | Genevini, Paola Papiani, Giulia Ruggiano, Annamaria Cantoni, Lavinia Navone, Francesca Borgese, Nica |
author_sort | Genevini, Paola |
collection | PubMed |
description | VAPB is a ubiquitously expressed, ER-resident adaptor protein involved in interorganellar lipid exchange, membrane contact site formation, and membrane trafficking. Its mutant form, P56S-VAPB, which has been linked to a dominantly inherited form of Amyotrophic Lateral Sclerosis (ALS8), generates intracellular inclusions consisting in restructured ER domains whose role in ALS pathogenesis has not been elucidated. P56S-VAPB is less stable than the wild-type protein and, at variance with most pathological aggregates, its inclusions are cleared by the proteasome. Based on studies with cultured cells overexpressing the mutant protein, it has been suggested that VAPB inclusions may exert a pathogenic effect either by sequestering the wild-type protein and other interactors (loss-of-function by a dominant negative effect) or by a more general proteotoxic action (gain-of-function). To investigate P56S-VAPB degradation and the effect of the inclusions on proteostasis and on ER-to-plasma membrane protein transport in a more physiological setting, we used stable HeLa and NSC34 Tet-Off cell lines inducibly expressing moderate levels of P56S-VAPB. Under basal conditions, P56S-VAPB degradation was mediated exclusively by the proteasome in both cell lines, however, it could be targeted also by starvation-stimulated autophagy. To assess possible proteasome impairment, the HeLa cell line was transiently transfected with the ERAD (ER Associated Degradation) substrate CD3δ, while autophagic flow was investigated in cells either starved or treated with an autophagy-stimulating drug. Secretory pathway functionality was evaluated by analyzing the transport of transfected Vesicular Stomatitis Virus Glycoprotein (VSVG). P56S-VAPB expression had no effect either on the degradation of CD3δ or on the levels of autophagic markers, or on the rate of transport of VSVG to the cell surface. We conclude that P56S-VAPB inclusions expressed at moderate levels do not interfere with protein degradation pathways or protein transport, suggesting that the dominant inheritance of the mutant gene may be due mainly to haploinsufficiency. |
format | Online Article Text |
id | pubmed-4237408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42374082014-11-21 Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model Genevini, Paola Papiani, Giulia Ruggiano, Annamaria Cantoni, Lavinia Navone, Francesca Borgese, Nica PLoS One Research Article VAPB is a ubiquitously expressed, ER-resident adaptor protein involved in interorganellar lipid exchange, membrane contact site formation, and membrane trafficking. Its mutant form, P56S-VAPB, which has been linked to a dominantly inherited form of Amyotrophic Lateral Sclerosis (ALS8), generates intracellular inclusions consisting in restructured ER domains whose role in ALS pathogenesis has not been elucidated. P56S-VAPB is less stable than the wild-type protein and, at variance with most pathological aggregates, its inclusions are cleared by the proteasome. Based on studies with cultured cells overexpressing the mutant protein, it has been suggested that VAPB inclusions may exert a pathogenic effect either by sequestering the wild-type protein and other interactors (loss-of-function by a dominant negative effect) or by a more general proteotoxic action (gain-of-function). To investigate P56S-VAPB degradation and the effect of the inclusions on proteostasis and on ER-to-plasma membrane protein transport in a more physiological setting, we used stable HeLa and NSC34 Tet-Off cell lines inducibly expressing moderate levels of P56S-VAPB. Under basal conditions, P56S-VAPB degradation was mediated exclusively by the proteasome in both cell lines, however, it could be targeted also by starvation-stimulated autophagy. To assess possible proteasome impairment, the HeLa cell line was transiently transfected with the ERAD (ER Associated Degradation) substrate CD3δ, while autophagic flow was investigated in cells either starved or treated with an autophagy-stimulating drug. Secretory pathway functionality was evaluated by analyzing the transport of transfected Vesicular Stomatitis Virus Glycoprotein (VSVG). P56S-VAPB expression had no effect either on the degradation of CD3δ or on the levels of autophagic markers, or on the rate of transport of VSVG to the cell surface. We conclude that P56S-VAPB inclusions expressed at moderate levels do not interfere with protein degradation pathways or protein transport, suggesting that the dominant inheritance of the mutant gene may be due mainly to haploinsufficiency. Public Library of Science 2014-11-19 /pmc/articles/PMC4237408/ /pubmed/25409455 http://dx.doi.org/10.1371/journal.pone.0113416 Text en © 2014 Genevini et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Genevini, Paola Papiani, Giulia Ruggiano, Annamaria Cantoni, Lavinia Navone, Francesca Borgese, Nica Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title | Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title_full | Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title_fullStr | Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title_full_unstemmed | Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title_short | Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model |
title_sort | amyotrophic lateral sclerosis-linked mutant vapb inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237408/ https://www.ncbi.nlm.nih.gov/pubmed/25409455 http://dx.doi.org/10.1371/journal.pone.0113416 |
work_keys_str_mv | AT genevinipaola amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel AT papianigiulia amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel AT ruggianoannamaria amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel AT cantonilavinia amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel AT navonefrancesca amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel AT borgesenica amyotrophiclateralsclerosislinkedmutantvapbinclusionsdonotinterferewithproteindegradationpathwaysorintracellulartransportinaculturedcellmodel |